Technical Analysis for WVE - WAVE Life Sciences Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| 20 DMA Support | Bullish | 0.16% | |
| NR7 | Range Contraction | 0.16% | |
| 20 DMA Support | Bullish | 3.00% | |
| Doji - Bullish? | Reversal | 3.00% | |
| Gapped Down | Weakness | 3.00% | |
| Outside Day | Range Expansion | 0.65% | |
| Wide Bands | Range Expansion | 1.48% |
| Alert | Time |
|---|---|
| Down 1% | 2 days ago |
| 60 Minute Opening Range Breakdown | 2 days ago |
| 10 DMA Resistance | 2 days ago |
| Up 3% | 2 days ago |
| Up 2% | 2 days ago |
Get a Trading Sidekick!
- Earnings date: 05/09/2024
WAVE Life Sciences Ltd. Description
WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company is developing nucleic acid therapeutics that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Its advanced therapeutic programs are in Huntington's disease, Duchenne muscular dystrophy (DMD), and inflammatory bowel disease (IBD). In Huntington's disease, it has programs targeting HTT SNP-1 and HTT SNP-2; in DMD, targeting Exon 51; and in IBD, targeting SMAD7. The company also has product candidates in its programs targeting HTT SNP-1 and Exon 51. In addition, it has late-stage discovery programs in epidermolysis bullosa simplex, targeting KRT14 SNP-1 and KRT14 SNP-2, as well as in DMD, focuses on an additional DMD target, AcRIIb. The company was founded in 2012 and is based in Singapore.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Acid Rare Diseases Medical Genetics Dysfunction Inflammatory Bowel Disease Dystrophy Muscular Dystrophy Huntington's Disease Duchenne Muscular Dystrophy Genodermatoses Duchenne Epidermolysis Bullosa Genetic Genealogy Cytoskeleton Dystrophin
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.6699 |
| 52 Week Low | 3.45 |
| Average Volume | 596,278 |
| 200-Day Moving Average | 5.25 |
| 50-Day Moving Average | 5.73 |
| 20-Day Moving Average | 6.02 |
| 10-Day Moving Average | 6.22 |
| Average True Range | 0.37 |
| RSI (14) | 56.71 |
| ADX | 17.51 |
| +DI | 26.35 |
| -DI | 18.70 |
| Chandelier Exit (Long, 3 ATRs) | 5.53 |
| Chandelier Exit (Short, 3 ATRs) | 6.05 |
| Upper Bollinger Bands | 6.50 |
| Lower Bollinger Band | 5.55 |
| Percent B (%b) | 0.67 |
| BandWidth | 15.78 |
| MACD Line | 0.17 |
| MACD Signal Line | 0.17 |
| MACD Histogram | -0.002 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 6.66 | ||||
| Resistance 3 (R3) | 6.68 | 6.55 | 6.58 | ||
| Resistance 2 (R2) | 6.55 | 6.42 | 6.54 | 6.55 | |
| Resistance 1 (R1) | 6.36 | 6.35 | 6.30 | 6.34 | 6.53 |
| Pivot Point | 6.23 | 6.23 | 6.19 | 6.22 | 6.23 |
| Support 1 (S1) | 6.04 | 6.10 | 5.98 | 6.02 | 5.83 |
| Support 2 (S2) | 5.91 | 6.03 | 5.90 | 5.81 | |
| Support 3 (S3) | 5.72 | 5.91 | 5.78 | ||
| Support 4 (S4) | 5.70 |
